Psychometric Properties of the Advance Care Planning Engagement Survey-9 in Cardiovascular and Metabolic Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Heo, Seongkum | - |
dc.contributor.author | Kim, Sun Hwa | - |
dc.contributor.author | Heo, Ran | - |
dc.contributor.author | Cho, KyungAh | - |
dc.contributor.author | Yang, Jisun | - |
dc.contributor.author | Kim, Hee Ryang | - |
dc.contributor.author | An, Minjeong | - |
dc.contributor.author | Kang, JungHee | - |
dc.contributor.author | Kim, JinShil | - |
dc.date.accessioned | 2024-02-10T16:30:21Z | - |
dc.date.available | 2024-02-10T16:30:21Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 1522-2179 | - |
dc.identifier.issn | 1539-0705 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90373 | - |
dc.description.abstract | The purpose of this study was to test the reliability and validity of the Advance Care Planning Engagement Survey-9 Korean version in patients with cardiovascular diseases or metabolic syndrome. In this cross-sectional study, data on advance care planning engagement, registration of advance directives and the intention, and sociodemographic characteristics were collected from 105 patients (mean age, 66.3 years) at 4 medical institutions. Cronbach alpha was used to test the reliability. Confirmatory factor analysis and independent t tests were used to test the validity. Cronbach alpha s for the total scale and the self-efficacy and readiness dimensions were .93, .82, and .97, respectively. In confirmatory factor analysis with 2 factors, all indices of model fit were acceptable: comparative fit index, 0.995; Tucker-Lewis index, 0.989; standardized root-mean-square residual, 0.024; root-mean-square error of approximation, 0.059; and factor loadings > 0.65. Patients who registered advance directives (P < .001) or had the intention (P < .001) had higher scores of the Advance Care Planning Engagement Survey-9 Korean version than their counterparts. The findings demonstrate that the Advance Care Planning Engagement Survey-9 Korean version was a reliable and valid instrument. Health care providers, including nurses, can use this instrument to assess and manage advance care planning engagement in Korean patients with cardiovascular diseases or metabolic syndrome. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.title | Psychometric Properties of the Advance Care Planning Engagement Survey-9 in Cardiovascular and Metabolic Diseases | - |
dc.type | Article | - |
dc.identifier.wosid | 001141983300004 | - |
dc.identifier.doi | 10.1097/NJH.0000000000001007 | - |
dc.identifier.bibliographicCitation | JOURNAL OF HOSPICE & PALLIATIVE NURSING, v.26, no.1, pp E30 - E37 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85182028199 | - |
dc.citation.endPage | E37 | - |
dc.citation.startPage | E30 | - |
dc.citation.title | JOURNAL OF HOSPICE & PALLIATIVE NURSING | - |
dc.citation.volume | 26 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | advance care planning | - |
dc.subject.keywordAuthor | cardiovascular diseases | - |
dc.subject.keywordAuthor | metabolic diseases | - |
dc.subject.keywordAuthor | validity and reliability | - |
dc.relation.journalResearchArea | Nursing | - |
dc.relation.journalWebOfScienceCategory | Nursing | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.